You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
CHICAGO (GenomeWeb) – NantHealth, fresh off a tough 2017 that saw the company cut 300 jobs and face a series of lawsuits related to its 2016 initial public offering, is betting on new technology and assays to carry it into the future.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Antibody testing is expected to play an important role in the management of the COVID-19 pandemic.
As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.
As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.